Casey Johnson

2.3k citations

19 papers · 1.8k indexed · h-index 15

Impact in

Infectious Diseases top 2%
- Viral Infections and Vectors
- Viral Infections and Outbreaks Research
Epidemiology top 5%
- Influenza Virus Research Studies
- Respiratory viral infections research

Papers in ⓘ

Immunology 8
- Immune Response and Inflammation 6
- Immunotherapy and Immune Responses 2
Infectious Diseases 7
- Viral Infections and Outbreaks Research 4
- Viral Infections and Vectors 4

Co-authors: Lynda Tussey (5 shared papers)David N. Taylor (4 shared papers)Uma Kavita (4 shared papers)Alan Shaw (4 shared papers)Thomas P. Monath (5 shared papers)Penelope Ward (1 shared paper)Dávid Paár (1 shared paper)Frederick G. Hayden (1 shared paper)
Journals: Vaccine (6 papers)The Journal of Infectious Diseases (5 papers)New England Journal of Medicine (2 papers)Open Forum Infectious Diseases (2 papers)Human Vaccines & Immunotherapeutics (1 paper)
Partner nations: United States Germany Belgium

In The Last Decade

Casey Johnson

19 papers receiving 1.7k citations

Peers

Countries citing papers authored by Casey Johnson

Since Specialization

Citations

This map shows the geographic impact of Casey Johnson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Casey Johnson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Casey Johnson more than expected).

Fields of papers citing papers by Casey Johnson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Casey Johnson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Casey Johnson. The network helps show where Casey Johnson may publish in the future.

Co-authors

The 25 scholars most cited alongside Casey Johnson, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Casey Johnson Line = papers co-authored together Casey Johnson links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

#	Work
1	Use of the Selective Oral Neuraminidase Inhibitor Oseltamivir to Prevent Influenza New England Journal of Medicine ·Frederick G. Hayden, Robert L. Atmar, M. Schilling, Casey Johnson, Donald M. Poretz, Dávid Paár, Les Huson, Penelope Ward, Roger Mills	1999	384
2	Safety and immunogenicity of a recombinant M2e–flagellin influenza vaccine (STF2.4xM2e) in healthy adults Vaccine ·Christine B. Turley, Richard Rupp, Casey Johnson, David N. Taylor, Julie Wolfson, Lynda Tussey, Uma Kavita, Lawrence R. Stanberry, Alan Shaw	2011	249
3	Chimeric Live, Attenuated Vaccine against Japanese Encephalitis (ChimeriVax‐JE): Phase 2 Clinical Trials for Safety and Immunogenicity, Effect of Vaccine Dose and Schedule, and Memory Response to Challenge with Inactivated Japanese Encephalitis Antigen The Journal of Infectious Diseases ·Thomas P. Monath, Farshad Guirakhoo, Richard Nichols, Sutee Yoksan, Robert Schrader, Chris Murphy, Paul S. Blum, Stephen Woodward, Karen McCarthy, Danell Mathis, Casey Johnson, Philip Bedford	2003	165
4	Clinical proof of principle for ChimeriVax™: recombinant live, attenuated vaccines against flavivirus infections Vaccine ·Thomas P. Monath, Karen McCarthy, Philip Bedford, Casey Johnson, Richard Nichols, Sutee Yoksan, Ron Marchesani, Michael Knauber, Keith H. Wells, Juan Arroyo, Farshad Guirakhoo	2002	164
5	A live, attenuated recombinant West Nile virus vaccine Proceedings of the National Academy of Sciences ·Thomas P. Monath, Jian Liu, Niranjan Kanesa-thasan, Gwendolyn A. Myers, Richard Nichols, Alison Deary, Karen McCarthy, Casey Johnson, Thomas H. Ermak, Sunheang Shin, Juan Arroyo, Farshad Guirakhoo, Jeffrey S. Kennedy, Francis A. Ennis, Sharone Green, Philip Bedford	2006	155
6	Induction of a potent immune response in the elderly using the TLR-5 agonist, flagellin, with a recombinant hemagglutinin influenza–flagellin fusion vaccine (VAX125, STF2.HA1 SI) Vaccine ·David N. Taylor, John J. Treanor, Cynthia Strout, Casey Johnson, Theresa Fitzgerald, Uma Kavita, Karen Ozer, Lynda Tussey, Alan Shaw	2011	132
7	Development of VAX128, a recombinant hemagglutinin (HA) influenza-flagellin fusion vaccine with improved safety and immune response Vaccine ·David N. Taylor, John J. Treanor, Eric Sheldon, Casey Johnson, Scott Umlauf, Langzhou Song, Uma Kavita, Ge Liu, Lynda Tussey, Karen Ozer, Thomas Hofstaetter, Alan Shaw	2012	102
8	An Inactivated Cell-Culture Vaccine against Yellow Fever New England Journal of Medicine ·Thomas P. Monath, Elizabeth Fowler, Casey Johnson, John Balser, Merribeth J. Morin, Maggie Sisti, Dennis W. Trent	2011	84
9	Safety and Cross‐Reactive Immunogenicity of Candidate AS03‐Adjuvanted Prepandemic H5N1 Influenza Vaccines: A Randomized Controlled Phase 1/2 Trial in Adults The Journal of Infectious Diseases ·Joanne M. Langley, Louise Frenette, Linda Ferguson, Dennis Riff, Eric Sheldon, George Risi, Casey Johnson, Ping Li, Richard T. Kenney, Bruce L. Innis, Louis Fries	2010	76
10	Immunopotentiation of Trivalent Influenza Vaccine When Given with VAX102, a Recombinant Influenza M2e Vaccine Fused to the TLR5 Ligand Flagellin PLoS ONE ·H. Keipp Talbot, Michael T. Rock, Casey Johnson, Lynda Tussey, Uma Kavita, Anita Shanker, Alan Shaw, David N. Taylor	2010	68
11	Safety and immunogenicity of a novel nanoemulsion mucosal adjuvant W805EC combined with approved seasonal influenza antigens Vaccine ·Lawrence R. Stanberry, Jakub K. Simon, Casey Johnson, Philip L Robinson, Jingga Morry, Mary Flack, S. Gracon, Andrzej Myc, Tarek Hamouda, James R. Baker	2011	53
12	Safety and Immunogenicity of 3 Formulations of an Investigational Respiratory Syncytial Virus Vaccine in Nonpregnant Women: Results From 2 Phase 2 Trials The Journal of Infectious Diseases ·Jiřı́ Beran, Jason D. Lickliter, Tino F. Schwarz, Casey Johnson, Laurence Chu, Joseph B. Domachowske, Pierre Van Damme, Kanchanamala Withanage, Laurence Fissette, Marie‐Pierre David, Koen Maleux, Alexander C. Schmidt, Marta Picciolato, Ilse Dieussaert	2018	35
13	Phase 1 Safety and Immunogenicity Study of a Quadrivalent Seasonal Flu Vaccine Comprising Recombinant Hemagglutinin-Flagellin Fusion Proteins Open Forum Infectious Diseases ·Lynda Tussey, Cynthia Strout, Matthew Davis, Casey Johnson, Gregg Lucksinger, Scott Umlauf, Langzhou Song, Ge Liu, Katalin G. Abraham, C. J. White	2016	31
14	Three Dose Levels of a Maternal Respiratory Syncytial Virus Vaccine Candidate Are Well Tolerated and Immunogenic in a Randomized Trial in Nonpregnant Women The Journal of Infectious Diseases ·Tino F. Schwarz, Casey Johnson, Christine Grigat, Dan Apter, Péter Csonka, Niklas Lindblad, Thi Lien-Anh Nguyên, (unknown), Hui Qian, Antonella N. Tullio, Ilse Dieussaert, Marta Picciolato, Ouzama Henry	2021	29
15	Immunogenicity and safety of lyophilized and liquid dengue tetravalent vaccine candidate formulations in healthy adults: a randomized, phase 2 clinical trial Human Vaccines & Immunotherapeutics ·M. Turner, Athanasia Papadimitriou, Peter Winkle, Nathan Segall, Michael C. Levin, Matthew W. Doust, Casey Johnson, Gregg Lucksinger, Carlos Fierro, Paul Pickrell, Marsha G. Raanan, Vianney Tricou, Astrid Borkowski, Derek Wallace	2020	24
16	Safety and immunogenicity of fully liquid and lyophilized formulations of an investigational trivalent group B streptococcus vaccine in healthy non-pregnant women: Results from a randomized comparative phase II trial Vaccine ·Jiřı́ Beran, Geert Leroux‐Roels, Pierre Van Damme, Jan de Hoon, Corinne Vandermeulen, Mohamed Al‐Ibrahim, Casey Johnson, James T. Peterson, Sherryl Baker, Cláudia Seidl, Annette Dreisbach, Annette Karsten, Bartholomew Corsaro, Ouzama Henry, Maria Lattanzi, Zourab Bebia	2020	8
17	Exercise-Induced Serum Enzyme Elevations Confounding the Evaluation of Investigational Drug Toxicity: Report of Two Cases in a Vaccine Trial Human Vaccines ·Casey Johnson, Thomas P. Monath, Niranjan Kanesa-thasan, Danell Mathis, Chuck Miller, Seth Shapiro, Richard Nichols, Karen McCarthy, Alison Deary, Philip Bedford	2005	7
18	Safety and Immunogenicity of Cell Culture-Derived A/H3N2 Variant Influenza Vaccines: A Phase I Randomized, Observer-Blind, Dose-Ranging Study The Journal of Infectious Diseases ·Casey Johnson, Matthew Hohenboken, Terry L. Poling, Peter Jaehnig, Niranjan Kanesa-thasan	2014	6
19	1239. Different Dose Levels of a Respiratory Syncytial Virus Maternal Vaccine Candidate (RSVPreF3) Administered to Non-pregnant Women in a Randomized Clinical Trial Are Immunogenic and Well Tolerated Open Forum Infectious Diseases ·Tino F. Schwarz, Casey Johnson, Christine Grigat, Dan Apter, Péter Csonka, Niklas Lindblad, Thi Lien-Anh Nguyên, (unknown), Jyoti Soni, Antonella N. Tullio, Ilse Dieussaert, Marta Picciolato, Ouzama Henry	2020	1

About Casey Johnson

Casey Johnson is a scholar working on Immunology, Infectious Diseases, Epidemiology, Modeling and Simulation and Public Health, Environmental and Occupational Health, having authored 19 papers that have together received 1.8k indexed citations. Recurring topics across this work include Respiratory viral infections research (10 papers), Influenza Virus Research Studies (9 papers), Immune Response and Inflammation (6 papers), Mosquito-borne diseases and control (5 papers), Viral Infections and Outbreaks Research (4 papers), Viral Infections and Vectors (4 papers), Neonatal Respiratory Health Research (3 papers) and Immunotherapy and Immune Responses (2 papers). The work is most often cited by research in Infectious Diseases (747 citations), Epidemiology (947 citations), Immunology (484 citations), Public Health, Environmental and Occupational Health (590 citations) and Endocrinology (69 citations). Casey Johnson has collaborated with scholars based in United States, Germany and Belgium. Frequent co-authors include Lynda Tussey, David N. Taylor, Uma Kavita, Alan Shaw, Thomas P. Monath, Penelope Ward, Dávid Paár, Frederick G. Hayden, Les Huson and Robert L. Atmar. Their work appears in journals such as Vaccine, The Journal of Infectious Diseases, New England Journal of Medicine, Open Forum Infectious Diseases and Human Vaccines & Immunotherapeutics.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact